NSE · AI Signal & Stock Analysis · Neutral
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for ERIS is Neutral → (moderate move); technical trend down-trend; trading at ₹1,385.40 (-0.73% today); neutral (RSI 40).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Moderate move |
|---|---|
| Technical trend | Down-trend (since 2026-07-22) |
| Price | ₹1,385.40 |
| Change today | -0.73% |
| RSI (14) | 40.40 |
| Relative volume | 0.12 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹18,826 Cr |
| P/E | 28.95 |
| Cap category | Mid Cap |
| 52-week high | -23.3% away |
| 52-week low | +9.6% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for ERIS (Eris Lifesciences Limited) is Neutral with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
ERIS's RSI is neutral (RSI 40). A reading above 70 is typically overbought and below 30 oversold.
ERIS is trading about 23% below its 52-week high and 10% above its 52-week low as of Aug 14 2026, 6:50 PM.
ERIS's market capitalisation is ₹18,826 Cr as of Aug 14 2026, 6:50 PM.
ERIS is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.